Adjuvant chemoendocrine therapy in postmenopausal breast cancer: cyclophosphamide, methotrexate, and fluorouracil dose and schedule may make a difference. International Breast Cancer Study Group
(Q41743704)
scientific article published on April 1, 1998
scientific article published on April 1, 1998
Language:
other details
description | scientific article published on April 1, 1998 |
External Links
(P356) |
10.1200/JCO.1998.16.4.1358
|
(P698) |
9552037
|